|
Published by: Kalorama Information
Published: Oct. 1, 1995 - 222 Pages Now 50% off the original sale price of $3,250.
Table of Contents
Chapter 1: Executive Summary
- Introduction to Autoimmune Diseases
- Drugs Used for the Treatment of Autoimmune Diseases
- Drugs Used for the Treatment of Asthma
- Beta Agonists
- Chromone Salts
- Oral Steroids
- Theophylline
- Topical Steroids
- Drugs Used for the Treatment of Insulin-Dependent Diabetes Mellitus
- Insulin
- Drugs Used for the Treatment of Multiple Sclerosis
- Corticosteroids
- Immunosuppressive Agents
- Interferon
- Drugs Used for the Treatment of Rheumatoid Arthritis
- Disease-Modifying Antirheumatic Drugs
- Nonsteroidal Anti-Inflammatory Drugs
- Steroids
- Drugs Used for the Treatment of Systemic Lupus Erythematosus
- Antimalarials
- Immunosuppressive Agents
- Nonsteroidal Anti-Inflammatory Drugs
- Steroids
- Drugs Used for the Treatment of Other Autoimmune Diseases
- Drugs for Psoriasis
- Issues and Trends
- Products in Development
- Asthma
- Corticosteroids
- Leukocyte Adhesion Inhibitors
- Leukotriene Inhibitors
- Neuropeptide Blockers
- Tryptase Inhibitors
- Diabetes Mellitus
- Hoffmann-La Roche
- Eli Lilly
- ProCyte
- Scios Nova
- Multiple Sclerosis
- AI-100
- Copolymer 1
- Desoxyspergualin
- Interferon Beta-1a
- Rheumatoid Arthritis
- Antitumor Necrosis Factor
- Cellular Adhesion Molecule Inhibitors
- Chemokine Inhibitors
- Fusion Toxins
- Matrix Metalloprotease Inhibitors
- Vaccine
- Systemic Lupus Erythematosus
- LJP 394
- Recent Drug Approvals
- Asthma
- Boehringer Ingelheim
- Glaxo
- Other Autoimmune Diseases
- Psoriasis
- Trends in Drug Research
- Treatments for Asthma
- Treatments for Insulin-Dependent Diabetes Mellitus
- Antibody Marker
- Diabetes Genes
- Virus Trigger
- Treatments for Multiple Sclerosis
- Cladribine
- Interferon Beta 1-a
- Oral Tolerance
- Vaccine
- Treatments for Rheumatoid Arthritis
- Antibiotic Therapy
- Chicken Collagen
- Endorphins
- Gammalinolenic Acid
- Treatments for Systemic Lupus Erythematosus
- Antibody-DNA Complex
- Mutant Gene
- Treatments for Other Autoimmune Diseases
- Psoriasis
- Scleroderma and Sjogren's Syndrome
- The Market
- Scope and Methodology
- Notes on the Data
- Market Overview
- Size of the Market
- Growth and Future Market
- Drugs Used for the Treatment of Asthma
- Drugs Used for the Treatment of Insulin-Dependent Diabetes Mellitus
- Insulin
- Drugs Used for the Treatment of Multiple Sclerosis
- Drugs Used for the Treatment of Rheumatoid Arthritis
- Drugs Used for the Treatment of Systemic Lupus Erythematosus
- Drugs Used for the Treatment of Other Autoimmune Diseases
- Drugs for Psoriasis
Chapter 2: Introduction To Autoimmune Diseases
- Autoimmune Diseases
- Asthma
- Clinical Picture
- Epidemiology
- Etiology
- Pathology
- Insulin-Dependent Diabetes Mellitus
- Clinical Picture
- Epidemiology
- Pathology
- Multiple Sclerosis
- Clinical Picture
- Epidemiology
- Etiology
- Pathology
- Rheumatoid Arthritis
- Clinical Picture
- Epidemiology
- Etiology
- Pathology
- Systemic Lupus Erythematosus
- Clinical Picture
- Epidemiology
- Etiology
- Pathology
- Other Autoimmune Diseases
- Psoriasis
- Clinical Picture
- Epidemiology
- Etiology
- Pathology
- Scleroderma
- Clinical Picture
- Epidemiology
- Etiology
- Sjogren's Syndrome
- Clinical Picture
- Epidemiology
- Etiology
Chapter 3: Drugs Used For The Treatment Of Autoimmune Diseases
- Drugs Used for the Treatment of Asthma
- Beta Agonists
- Chromone Salts
- Oral Steroids
- Theophylline Salts
- Topical Steroids
- Drugs Used for the Treatment of Insulin-Dependent Diabetes Mellitus
- Insulin
- Drugs Used for the Treatment of Multiple Sclerosis
- Corticosteroids
- Immunosuppressive Agents
- Interferon
- Drugs Used for the Treatment of Rheumatoid Arthritis
- Disease-Modifying Antirheumatic Drugs
- Antimalarials
- Gold Compounds
- Immunoregulatory Drugs
- Penicillamine
- Sulfasalazine
- Nonsteroidal Anti-Inflammatory Drugs
- Benzothiazine Derivatives
- Fenamates
- Indoleacetic Acid Derivatives
- Para-Aminophenol Derivatives
- Propionic Acid Derivatives
- Pyrazole Derivatives
- Pyrroleacetic Acid Derivatives
- Salicylates
- Steroids
- Third-Line Drugs
- Cyclophosphamide
- Cyclosporine
- Combination Therapy
- Juvenile Rheumatoid Arthritis Therapies
- Selecting Appropriate Therapies for Rheumatoid Arthritis
- Drugs Used for the Treatment of Systemic Lupus Erythematosus
- Antimalarials
- Immunosuppressive Agents
- Nonsteroidal Anti-Inflammatory Drugs
- Steroids
- Drugs Used for the Treatment of Other Autoimmune Diseases
- Drugs for Psoriasis
- Drugs for Scleroderma
- Drugs for Sjogren's Syndrome
Chapter 4: Issues And Trends
- Issues Affecting Drugs for Autoimmune Diseases
- Products in Development
- Asthma
- Corticosteroids
- Leukocyte Adhesion Inhibitors
- Leukotriene Inhibitors
- Neuropeptide Blockers
- Tryptase Inhibitors
- Diabetes Mellitus
- Hoffmann-La Roche
- Eli Lilly
- ProCyte
- Scios Nova
- Multiple Sclerosis
- AI-100
- Copolymer 1
- Desoxyspergualin
- Interferon Beta-1a
- Rheumatoid Arthritis
- Antitumor Necrosis Factor
- Cellular Adhesion Molecule Inhibitors
- Chemokine Inhibitors
- Fusion Toxins
- Matrix Metalloprotease Inhibitors
- Vaccine
- Systemic Lupus Erythematosus
- LJP 394
- Other Autoimmune Diseases
- Psoriasis
- Scleroderma
- Recent Drug Approvals
- Asthma
- Boehringer Ingelheim
- Glaxo
- Other Autoimmune Diseases
- Psoriasis
- Trends in Drug Research
- Treatments for Asthma
- Treatments for Insulin-Dependent Diabetes Mellitus
- Antibody Marker
- Diabetes Genes
- Virus Trigger
- Treatments for Multiple Sclerosis
- Cladribine
- Interferon Beta 1-a
- Oral Tolerance
- Vaccine
- Treatments for Rheumatoid Arthritis
- Antibiotic Therapy
- Chicken Collagen
- Endorphins
- Gammalinolenic Acid
- Treatments for Systemic Lupus Erythematosus
- Antibody-DNA Complex
- Mutant Gene
- Treatments for Other Autoimmune Diseases
- Psoriasis
- Capsaicin
- T Cells
- Scleroderma and Sjogren's Syndrome
- Protein Trigger
Chapter 5: The Market
- Scope And Methodology
- Notes on the Data
- Trends Affecting Market Estimates
- Population
- Market Overview
- Size of the Market
- Growth and Future Market
- Drugs Used for the Treatment of Asthma
- Beta Agonists
- Chromone Salts
- Oral Steroids
- Theophylline
- Topical Steroids
- Drugs Used for the Treatment of Insulin-Dependent Diabetes Mellitus
- Insulin
- Drugs Used for the Treatment of Multiple Sclerosis
- Drugs Used for the Treatment of Rheumatoid Arthritis
- Disease-Modifying Antirheumatic Drugs
- Nonsteroidal Anti-Inflammatory Drugs
- Steroids
- Drugs Used for the Treatment of Systemic Lupus Erythematosus
- Drugs Used for the Treatment of Other Autoimmune Diseases
- Drugs for Psoriasis
Chapter 6: Company Profiles
- Abbott Laboratories
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Strategic Alliances
- American Cyanamid Company
- History and Lines of Business
- Financial Information
- Research and Development
- Mergers and Acquisitions
- American Home Products Corporation
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Mergers and Acquisitions
- Anergen, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- Applied Immune Sciences, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- AutoImmune, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- BioCryst Pharmaceuticals, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- Biogen, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- Strategic Alliances
- Boehringer Ingelheim Gmbh
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Bristol-Myers Squibb Company
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
- Carter-Wallace, Inc.
- Lines of Business
- Financial Information
- Autoimmune Drug Products
- Celtrix Pharmaceuticals, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- Strategic Alliances
- Centocor, Inc.
- History and Lines of Business
- Financial Information
- Research and Development
- Chiron Corporation
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Strategic Alliances
- Ciba
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategy
- Forest Laboratories, Inc.
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Glaxo Holdings Plc
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Corporate Strategy
- Strategic Alliances
- The Immune Response Corporation
- History and Lines of Business
- Financial Information
- Research and Development
- Immunex Corporation
- Lines of Business
- Financial Information
- Research and Development
- Eli Lilly and Company
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategy
- Strategic Alliances
- Marion Merrell Dow Inc.
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Mergers and Acquisitions
- Merck & Company, Inc.
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Corporate Alliances
- Pfizer Inc.
- Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Strategic Alliances
- Rhone-Poulenc Rorer Inc.
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Strategic Alliances
- Roche Holdings Ltd.
- History and Lines of Business
- Financial Information
- Research and Development
- Mergers and Acquisitions
- Sandoz Ltd.
- Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
- Schering AG
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Schering-Plough Corporation
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Strategic Alliances
- Seragen, Inc.
- Lines of Business
- Financial Information
- Research and Development
- SmithKline Beecham Plc
- History and Lines Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Strategic Alliances
- Syntex Corporation
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Corporate Strategies
- Teva Pharmaceutical Industries Ltd.
- History and Lines of Business
- Financial Information
- Research and Development
- Strategic Alliances
- 3M
- Lines of Business
- Financial Information
- Autoimmune Drug Products
- Corporate Strategies
- Strategic Alliances
- The Upjohn Company
- Lines of Business
- Financial Information
- Autoimmune Drug Products
- Research and Development
- Vertex Pharmaceuticals, Inc.
- Lines of Business
- Financial Information
- Research and Development
- Strategic Alliances
- Wellcome Plc
- History and Lines of Business
- Financial Information
- Autoimmune Drug Products
- Zeneca Group Plc
- History and Lines of Business
- Financial Information
- Research and Development
Appendix A: Commonly Used Autoimmune Drugs
Appendix B: Company Names And Addresses
AbstractThe rising number of arthritis patients assures a healthy market for arthritis therapeutics. There will be high demand for Betaseron for the prevention of clinical exacerbations in multiple sclerosis patients. Treatment of systemic lupus erythematosus is now focused on using preventive medicine. This up-to-the-minute report by Kalorama Information analyzes the trends shaping the market and assesses the major available products and products in development. Included is an overview of the market, analysis by market segment—including historical data from 1990-1995 and forecasts to 2000—market trends and trends by product type for asthma, insulin-dependent diabetes, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus and psoriasis. Companies profiled include Abbott Laboratories, American Home Products, Bristol-Myers Squibb and Ciba.
Get Full Details About This Report >>
|
